Neffy is the first-ever FDA-approved nasal spray for the treatment of severe allergic reactions, and it offers an alternative to the current standard for emergencies, auto-injectable pens filled with epinephrine. This new drug only needs a single spray into a nostril, and it has been approved for children and adults weighing over 66 pounds.
“Anaphylaxis is life-threatening and some people, particularly children, may delay or avoid treatment due to fear of injections,” said Kelly Stone, MD, PhD, Associate Director of the Division of Pulmonology, Allergy and Critical Care in the FDA’s Center for Drug Evaluation and Research, “The availability of epinephrine nasal spray may reduce barriers to rapid treatment of anaphylaxis. As a result, Neffy provides an important treatment option and addresses an unmet need.”
#LifeSaving #Nasal #Sprays #neffy
